WGS/WES-RNAseq compared to targeted NGS in oncology: is there something to unlock?
Ann Oncol
.
2023 Dec;34(12):1090-1093.
doi: 10.1016/j.annonc.2023.09.3118.
Epub 2023 Oct 8.
Authors
M Aldea
1
,
D Vasseur
2
,
A Italiano
3
,
S I Nikolaev
4
Affiliations
1
Department of Medical Oncology, Gustave Roussy, Villejuif; Paris-Saclay University, Kremlin-Bicetre; Precision Medicine, Gustave Roussy, Villejuif.
2
Precision Medicine, Gustave Roussy, Villejuif; Department of Molecular Pathology, Gustave Roussy, Villejuif.
3
Precision Medicine, Gustave Roussy, Villejuif; Drug Development Department, Gustave Roussy, Villejuif.
4
Inserm U981, Gustave Roussy, Villejuif, France. Electronic address: sergey.nikolaev@gustaveroussy.fr.
PMID:
37816462
DOI:
10.1016/j.annonc.2023.09.3118
No abstract available
Publication types
Editorial
MeSH terms
Genome, Human*
High-Throughput Nucleotide Sequencing*
Humans